BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 18, 2009
View Archived Issues
Apoptosis inducers in early development at Chinese Academy of Medical Science
Read More
AstraZeneca reports second quarter 2009 results
Read More
VAK-694 safety and tolerability to be assessed by Novartis in allergic rhinitis phase II trial
Read More
Gilead presents studies of its pharmaco-enhancer GS-9350 in the treatment of HIV
Read More
Xinchang Pharmaceutical Factory claims novel anticancer compounds
Read More
Merz discloses mGluR5 modulators for the treatment of pain
Read More
Sativex is well tolerated and improves spasticity due to multiple sclerosis in clinical trial
Read More
ACE-011 active against bone loss in postmenopausal women
Read More
TBR-652 in vitro activity in combination with antiretrovirals and human pharmacokinetics reported
Read More
Botulinum toxin type A improves various Parkinson's disease symptoms
Read More
ONO-5334 shows potential for osteoporosis therapy in ovariectomized monkeys
Read More
Cell Therapeutics reports 18-month follow-up data from phase III pixantrone study
Read More
Biovex and FDA agree on design for pivotal phase III OncoVEX(GM-CSF) study
Read More
Cytavis initiates phase II aviscumine trial in metastatic colorectal carcinoma
Read More
DNage initiates observational study in children with Cockayne syndrome
Read More
EMEA recommends orphan drug designation of intravenous CP-4126 for pancreatic cancer
Read More
European Commission approves expanded use for raltegravir in adults with HIV
Read More
FDA clears D3 FastPoint L-DFATM respiratory virus identification kit
Read More
Hyperion Therapeutics enrolls first patient in HPN-100 trial in children with urea cycle disorders
Read More
Lexicon initiates phase II trial of LX-4211 in type 2 diabetes
Read More
Poniard presents update on pivotal phase III picoplatin trial in lung cancer
Read More
FDA grants orphan drug designation to Restanza for plague and tularemia
Read More
RX-100 shows potential in protecting against lethal whole-body radiation
Read More
ZaBeCor begins phase II Excellair trial in asthma patients
Read More
Seaside Therapeutics secures funding to support studies in autism and fragile X syndrome
Read More
FDA approves Valturna, a single-pill combination of aliskiren and valsartan
Read More